Biotechnology stocks have recently shown renewed strength, and improving momentum may just push these names toward the top of the leaderboard.
Second, this level also represented a 38.2% retracement level based on the 2021 high and 2022 low, which is a widely followed support level based on the Fibonacci methodology.
This week, IBB has bounced off that support level, making a new 52-week high as it briefly pushed above the 50% retracement level around $140.
The weekly chart reinforces that biotechnology stocks may still be in the early stages of this advance, with lots of daylight between current levels and the 2021 highs.
BEFORE MAKING ANY FINANCIAL DECISIONS, YOU SHOULD STRONGLY CONSIDER SEEKING ADVICE FROM YOUR OWN FINANCIAL OR INVESTMENT ADVISOR.
Persons:
IBB, David Keller
Organizations:
Biotechnology, Nasdaq Biotechnology, CMT